II
TCRT icon

Ibex Investors’s Alaunos Therapeutics TCRT Stock Holding History

Ibex Investors’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-238
Closed -$168K – 49
2019
Q4 		$168K Sell
238
-50
-17% -$34.4K ﹤0.01% 54
2019
Q3 		$185K Sell
288
-591
-67% -$469K 0.01% 36
2019
Q2 		$768 Sell
879
-356
-29% -$245K 0.06% 38
2019
Q1 		$713K Sell
1,235
-1,456
-54% -$609K 0.06% 48
2018
Q4 		$755K Buy
+2,691
New +$1.06M 0.12% 51

Other funds holding TCRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ibex Investors's TCRT Position: Q1 2020 in Review

Ibex Investors sold out of Alaunos Therapeutics (TCRT) in Q1 2020, closing a stake of 238 shares — an estimated $168K sold.

Ibex Investors first reported a position in TCRT in Q4 2018 and held it in 5 quarters. The position peaked at $755K in Q4 2018. 146 funds tracked by Wall St. Rank hold TCRT as of Q1 2020.

  • Ibex Investors reported no remaining Alaunos Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Ibex Investors sold 238 Alaunos Therapeutics shares in Q1 2020, an estimated $168K.
  • Ibex Investors first reported a position in Alaunos Therapeutics in Q4 2018 and held it in 5 quarters.
  • Ibex Investors's Alaunos Therapeutics position peaked at $755K in Q4 2018.
  • 146 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2020.

Based on Ibex Investors's 13F filing for Q1 2020, filed 14 May 2020.